Long-term use of acid-suppressive therapy after the endoscopic diagnosis of reflux esophagitis

Diseases of the Esophagus

Volumn 13, Issue 4, 2000, Pages 271-274

  Boom, H D ^a   Loffeld, R J L F ^a  

^a ZAANS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CISAPRIDE; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG MONITORING; DRUG USE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; REFLUX ESOPHAGITIS; RELAPSE; RETROSPECTIVE STUDY;

ANTACIDS; ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RECURRENCE; TIME FACTORS;

EID: 0034449455     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2000.00131.x     Document Type: Article

References (17)

1. The pathogenesis of gastroesophageal reflux disease
2. Gastric symptoms and duodenogastric reflux in patients referred for gastroesophageal reflux symptoms and endoscopic esophagitis
3. Multivariate analysis of pathophysiological factors in reflux oesophagitis
4. The presentation of reflux oesophagitis, hiatal hernia, Barrett's oesophagus and 'reflux-like' dyspepsia: A prospective clinical and endoscopical study
5. Predictive factors of long term outcome in gastro-oesophageal reflux disease: Six year follow-up of 107 patients
6. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease
7. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis - A 2-year follow-up
8. Symptomatic gastro-oesophageal reflux disease. Double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group
9. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: A meta-analysis of long-term omeprazole trials
10. Factors predicting relapse during maintenance treatment with Famotidine in patients with healed reflux esophagitis
11. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: A US multi-centre double blind study
12. A comparison of five maintenance therapies for reflux oesophagitis
13. Natural history of reflux oesophagitis: A 10 year follow-up of its effect on patient symptomatology and quality of life
14. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - A placebo controlled randomised trial
15. Three year follow-up of patients with gastroesophageal reflux disease
16. Long-term management of gastroesophageal reflux disease